HRT FINANCIAL LP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,129
+172.8%
81,934
+157.6%
0.03%
+181.8%
Q2 2023$1,147
-59.2%
31,807
-56.8%
0.01%
-67.6%
Q1 2023$2,811
-21.0%
73,629
+17.7%
0.03%
-32.0%
Q4 2022$3,559
-99.5%
62,562
+252.6%
0.05%
+525.0%
Q3 2022$701,000
-79.7%
17,745
-77.4%
0.01%
-78.9%
Q2 2022$3,448,000
+141.3%
78,374
+120.5%
0.04%
+375.0%
Q4 2021$1,429,000
+62.6%
35,547
+68.5%
0.01%
-11.1%
Q1 2021$879,000
+260.2%
21,092
+53.0%
0.01%
-10.0%
Q4 2019$244,000
-23.5%
13,789
-33.1%
0.01%
-33.3%
Q3 2019$319,00020,6060.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders